Ks. Tan et al., EFFECTS OF EXOGENOUS FEMALE SEX-STEROID HORMONES ON LYMPHOCYTE BETA(2)-ADRENOCEPTORS IN NORMAL FEMALES, British journal of clinical pharmacology, 41(5), 1996, pp. 414-416
We have previously shown that lymphocyte beta(2)-adrenoceptors (AR) ar
e under cyclical control of sex-steroid hormones with greater receptor
density during the luteal phase of the menstrual cycle. It has also b
een postulated that abnormal cyclical regulation of beta(2)-AR might b
e a possible mechanism for premenstrual asthma. The effects of exogeno
us female sex-steroid hormones on lymphocyte beta(2)-AR function were
studied in eight normal healthy females. They were evaluated at two su
ccessive menstrual cycles, during the follicular phase (day 1-6). They
were randomized to receive single oral doses of either ethinyloestrad
iol 50 mu g or medroxyprogesterone 10 mg in a cross-over study. Lympho
cyte beta(2)-AR parameters were evaluated at baseline (t(0)), 24 h (t(
24)) and 72 h (t(72)) after ingestion. Baseline levels of progesterone
and oestradiol were comparable on both cycles. Receptor density (beta
(max)) increased significantly (P<0.01) from t(0) after progesterone b
ut not oestradiol at t(24): a 1.39-fold geometric mean difference (95%
CI 0.96-2.00) between t(24) vs t(0). Receptor affinity (K-d) and maxi
mal cAMP response to isoprenaline (E(max)) were not altered by either
treatment. These results show that exogenous progesterone but not oest
radiol, given during the follicular phase, significantly increased bet
a(2)-AR. This, therefore, suggests that endogenous progesterone is pro
bably responsible for previously observed increase in B-max during the
luteal phase of the female menstrual cycle. These findings may sugges
t possible therapeutic strategies for modulation of beta(2)-AR in prem
enstrual asthma.